News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

A magnifying glass gives a close-up view of a strand of DNA. The DNA strand is set against a backdrop of buildings and houses, simulating a neighborhood. The illustration shows the value of understanding gene expression across the cell’s neighborhood.

Tool Unlocks Data’s Potential to Learn More About Cell Neighborhoods

See how a new NCI-funded tool is helping scientists learn more about spatial gene expression, enabling them to use these data to better understand how cells relate—with their neighbors and within the tumor environment.

A DNA strand is seen radiating from a toolbox full of tools. Illustration shows how scientists have many tools for use in DNA analysis.

MuSiCal—A New NCI-Funded Tool for Analyzing Genetic Mutations

Want to identify existing gene mutations more accurately and discover new signatures more efficiently? There’s a new NCI-funded tool, the Mutational Signature Calculator, that can help improve your standard workflow.

A cancer cell is highlighted in orange against a blue background that consists of other cancer and immune cells. The orange cell is in crosshairs, indicating that it’s being targeted for destruction.

Model Helps Predict Protein’s Immune-Boosting Ability

Are you researching immunotherapies and having trouble predicting which epitope will deliver the biggest punch? Try this new model for predicting immunogenicity, which is reportedly outperforming current models.

Teal DNA strand made up of code

New Notebook Demonstrates Machine Learning in Google BigQuery Using Updated Mitelman Database

In the “Mitelman Gene Fusions in TCGA” notebook, ISB Cancer Gateway in the Cloud (an NCI Cloud Resource) identified the most common gene fusions in prostate adenocarcinoma, demonstrating machine learning in Google BigQuery.

Magnifying glass over letters and numbers.

R Package Helps Scientific Software Developers Track and Monitor Usage

Use “metricminer” to discover the effectiveness of your software evaluations and expand the reach and impact of your scientific software.

Text on blue background with small blue dots. Text reads, "Funding Opportunity."

NCI Funding Opportunities for Measuring the Validity of Currently Existing Digital Health and AI/ML Technologies

NIH Institutes and Centers (including NCI) are interested in the validity, reliability, and utility of digital health tools and artificial intelligence/machine learning (AI/ML) technologies. You can apply for NCI funding to support the validation of these technologies for cancer research.

3-D rendering of a DNA strand. A section of the two strands is highlighted to show how researchers are studying tiny variants in DNA to see how they impact gene expression and, potentially, cancer.

New Platform for Prioritizing Genetic Variants Underlying Cancer Risk

Are you having trouble prioritizing which genetic variants to study in your cancer research? There’s a new platform, called FORGEdb, that can help you pinpoint promising variants and target genes.

A stethoscope and a strand of DNA blended together denotes a new tool that allows researchers to more easily integrate clinical and genetic data.

cBioPortal Updates Offer Joint Analysis of Genetic and Clinical Data

Interested in blending clinical and genetic data? Upgrades in cBioPortal can help you work with these very different data types to better understand cancer and how it progresses over time.

Face in profile with letters AI in center and stylized interconnected data points.

Up to $50k in Prizes for AI-Readiness Challenge on NCI Data

Participate in the upcoming challenge to assess NCI Cancer Research Data Commons' compatibility with AI/ML technologies.

laptop that shows charts, pie graphs, and line graphcs

Get Your Data Science Research Funded Through NCI DCCPS

Do you conduct research on statistical and analytical methods, cancer survivorship, digital health, and/or data science tools and methods? Apply for an R01 grant from NCI’s Division of Cancer Control and Population Sciences by June 5 or October 5, 2024.

SUBSCRIBE TO UPDATES

Categories

Archive